• Mashup Score: 2
    Financial Outcomes of “Bagging” Oncology Drugs Among Privately Insured Patients With Cancer - 8 month(s) ago

    This cohort study examines the difference in per-patient per-month costs between drugs distributed under “bagging,” a drug delivery model that requires patients to obtain physician-administered medications via pharmacies, and traditional buy-and-bill practice.

    Source: jamanetwork.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of RyanNipp
      RyanNipp

      Financial Outcomes of “Bagging” Oncology Drugs Among Privately Insured Patients With #Cancer. https://t.co/6MILn1higb @MDAndersonNews @JAMA_current @JAMANetworkOpen #CostsOfCare #FinancialToxicity #PallOnc https://t.co/kuhrrNR4lz

  • Mashup Score: 5
    U.S. Announces First Drugs Picked for Medicare Price Negotiations - 9 month(s) ago

    The Biden administration’s announcement was an important moment for Democrats, who have campaigned on a promise to lower the cost of prescription drugs.

    Source: www.nytimes.com
    Categories: Latest Headlines, Oncologists1
    Tweet Tweets with this article
    • Profile photo of fumikochino
      fumikochino

      Happy for the #InflationReductionAct & its promise to lower the cost of Rx drugs for those on Medicare... BUT I was really hoping for Ibrance/Palbociclib on this list to improve access & reduce #financialToxicity for our pts w #mBC #BreastCancer #bcsm💊🫥 https://t.co/571ERnPmQ1 https://t.co/qcgaY37JsL

  • Mashup Score: 7
    U.S. Announces First Drugs Picked for Medicare Price Negotiations - 9 month(s) ago

    The Biden administration’s announcement was an important moment for Democrats, who have campaigned on a promise to lower the cost of prescription drugs.

    Source: www.nytimes.com
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DrSGraff
      DrSGraff

      For the #HemOnc crowd—making the list are Eliquis, Xarelto, and Imbruvica #MedTwitter #financialtoxicity First Drugs Picked for Medicare Price Negotiations https://t.co/t2i5qfzBqW

    • Profile photo of mchonig
      mchonig

      First 10 drugs selected for Medicare price negotiations 👀👀 https://t.co/uxcH3Mm8oF https://t.co/JN3fBYLvoA

    • Profile photo of GendronNico
      GendronNico

      RT @pnatarajanmd: First 10 medicines subject to price negotiations with Medicare announced https://t.co/6F86AikjWz @nytimes @nytpolitics ht…

  • Mashup Score: 10
    Effect of a Community Health Worker–Led Intervention Among Low-Income and Minoritized Patients With Cancer: A Randomized Clinical Trial - 9 month(s) ago

    PURPOSE To determine whether a community health worker (CHW)–led intervention could improve health-related quality of life (HRQoL; primary outcome) more than usual care among low-income and racial and ethnic minoritized populations newly diagnosed with cancer. METHODS This randomized clinical trial was conducted from November 1, 2018, until August 31, 2021, in outpatient cancer clinics in Atlantic City, NJ, and Chicago, IL. Hourly low-wage worker members of an employer union health fund age 18 years or older with newly diagnosed solid tumor and hematologic malignancies were randomly assigned 1:1 to usual care (control group) or usual care augmented with a trained CHW for 12 months (intervention group). The CHW assisted participants with advance care planning (ACP), proactively screened symptoms, and referred participants to community-based resources for identified health-related social needs. Usual care comprised nurse case management and benefits redesign (waived copayments and free t

    Source: ascopubs.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of RyanNipp
      RyanNipp

      Effect of a Community Health Worker-Led Intervention Among Low-Income and Minoritized Patients With #Cancer: A Randomized Clinical Trial. https://t.co/75DwyjLrIm @ASCO @JCO_ASCO @manalipatelmd #PallOnc #FinancialToxicity #CancerResearch https://t.co/wgdnhGsfml

  • Mashup Score: 10
    Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39) - 9 month(s) ago

    PURPOSE Financial toxicity (FT) affects 20% of cancer survivors and is associated with poor clinical outcomes. No large-scale programs have been implemented to mitigate FT. We evaluated the effect of monthly FT screening as part of a larger patient-reported outcomes (PROs) digital monitoring intervention. METHODS PRO-TECT (AFT-39) is a cluster-randomized trial of patients undergoing systemic therapy for metastatic cancer. Practices were randomly assigned 1:1 to digital symptom monitoring (PRO practices) or usual care (control practices). Digital monitoring consisted of between-visit online or automated telephone patient surveys about symptoms, functioning, and FT (single-item screening question from Functional Assessment of Chronic Illness Therapy-COmprehensive Score for financial Toxicity) for up to 1 year, with automated alerts sent to practice nurses for concerning survey scores. Clinical team actions in response to alerts were not mandated. The primary outcome of this planned secon

    Source: ascopubs.org
    Categories: Hem/Oncs, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of RyanNipp
      RyanNipp

      Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During #Cancer Treatment (Alliance AFT-39). https://t.co/ndjwfJvcep @ASCO @JCO_ASCO @EthanBasch1 #FinancialToxicity #PallOnc #CancerResearch https://t.co/QFXKYLnDmw

  • Mashup Score: 0
    Overcoming Financial Toxicity From Cancer - The ASCO Post - 9 month(s) ago

    I knew the moment my fingers found a lump in my left breast, in 2018, that it was cancer, and I wondered if I was going to die. My maternal grandmother had been diagnosed with breast cancer when she was 39, the same age I was when I discovered the mass in my breast. She died 5 years later. Divorced and the sole supporter and guardian of my then 15-year-old daughter, I knew that whatever this lump turned out to be, I would do everything I could to survive. After discovering the mass, I made an appointment

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Overcoming Financial Toxicity From Cancer, by Keneene Lewis, MEd, BSM https://t.co/NeWciqvnhK #cancer #costofcare #financialtoxicity

Load More